Tag: Swedish biotech company
Akiram Therapeutics research selected as Top Rated Oral Presentations at EANM...
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, will contribute to several academic presentations at the EANM Congress 2025 in Barcelona, October...
Akiram’s Phase I clinical trial with AKIR001 progresses to next step
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, has announced the completion of the first cohort in the clinical Phase I trial...
Clinical trial of Akiram’s cancer drug candidate AKIR001
Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, announced that the first patient has been enrolled in the Phase 1 clinical trial...